6 studies found for:    E2609
Show Display Options
Rank Status Study
1 Completed Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
Condition: Alzheimer's Disease
Interventions: Drug: E2609;   Drug: Placebo for E2609
2 Completed An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects
Condition: Metabolism and Elimination
Intervention: Drug: E2609
3 Completed Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects
Condition: Healthy
Interventions: Drug: E2609;   Drug: Placebo
4 Completed A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
Condition: Healthy Subjects
Interventions: Drug: E2609;   Drug: itraconazole;   Drug: rifampin;   Drug: digoxin;   Drug: donepezil
5 Completed An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption
Condition: Alzheimer's Disease
Intervention: Drug: E2609
6 Completed Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort
Condition: Alzheimer's Disease
Interventions: Drug: Drug: E2609;   Drug: Placebo

Indicates status has not been verified in more than two years